Cooper Companies Inc., The (COO)

$96.75

-1.03

(-1.05%)

Market is closed - opens 8 PM, 26 Feb 2024

Performance

  • $96.05
    $97.86
    $96.75
    downward going graph

    0.72%

    Downside

    Day's Volatility :1.85%

    Upside

    1.13%

    downward going graph
  • $75.94
    $99.90
    $96.75
    downward going graph

    21.51%

    Downside

    52 Weeks Volatility :23.98%

    Upside

    3.15%

    downward going graph

Returns

PeriodCooper Companies Inc., The
3 Months
11.03%
6 Months
0.17%
1 Year
347.8%
3 Years
279.48%

Highlights

Market Capitalization
19.4B
Book Value
$38.14
Dividend Share
0.015
Dividend Yield
0.02%
Earnings Per Share (EPS)
1.48
PE Ratio
66.07
PEG Ratio
12.05
Wall Street Target Price
97.79
Profit Margin
8.19%
Operating Margin TTM
14.98%
Return On Assets TTM
2.72%
Return On Equity TTM
4.0%
Revenue TTM
3.6B
Revenue Per Share TTM
18.15
Quarterly Revenue Growth YOY
9.3%
Gross Profit TTM
2.4B
EBITDA
872.2M
Diluted Eps TTM
1.48
Quarterly Earnings Growth YOY
0.28
EPS Estimate Current Year
3.46
EPS Estimate Next Year
3.9
EPS Estimate Current Quarter
3.48
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    50%Buy
    50%Hold
    0
    0%Sell
Based on 22 Wall street analysts offering stock ratings for Cooper Companies Inc., The(by analysts ranked 0 to 5 stars)
Based on 22 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
11
10
12
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1.07%

Current $96.75
Target $97.79

Company Financials

FY18Y/Y Change
Revenue
2.5B
↑ 18.41%
Net Income
139.9M
↓ 62.48%
Net Profit Margin
5.52%
↓ 11.91%
FY19Y/Y Change
Revenue
2.7B
↑ 4.76%
Net Income
466.7M
↑ 233.6%
Net Profit Margin
17.59%
↑ 12.07%
FY20Y/Y Change
Revenue
2.4B
↓ 8.39%
Net Income
238.4M
↓ 48.92%
Net Profit Margin
9.81%
↓ 7.78%
FY21Y/Y Change
Revenue
2.9B
↑ 20.22%
Net Income
2.9B
↑ 1135.19%
Net Profit Margin
100.76%
↑ 90.95%
FY22Y/Y Change
Revenue
3.3B
↑ 13.2%
Net Income
385.8M
↓ 86.9%
Net Profit Margin
11.66%
↓ 89.1%
FY23Y/Y Change
Revenue
3.6B
↑ 8.61%
Net Income
294.2M
↓ 23.74%
Net Profit Margin
8.19%
↓ 3.47%
Q3 FY22Q/Q Change
Revenue
843.4M
↑ 1.64%
Net Income
98.4M
↓ 22.27%
Net Profit Margin
11.67%
↓ 3.59%
Q4 FY22Q/Q Change
Revenue
848.1M
↑ 0.56%
Net Income
65.6M
↓ 33.33%
Net Profit Margin
7.73%
↓ 3.94%
Q1 FY23Q/Q Change
Revenue
858.5M
↑ 1.23%
Net Income
84.6M
↑ 28.96%
Net Profit Margin
9.85%
↑ 2.12%
Q2 FY23Q/Q Change
Revenue
877.4M
↑ 2.2%
Net Income
39.8M
↓ 52.96%
Net Profit Margin
4.54%
↓ 5.31%
Q3 FY23Q/Q Change
Revenue
930.2M
↑ 6.02%
Net Income
85.3M
↑ 114.32%
Net Profit Margin
9.17%
↑ 4.63%
Q4 FY23Q/Q Change
Revenue
927.1M
↓ 0.33%
Net Income
84.5M
↓ 0.94%
Net Profit Margin
9.11%
↓ 0.06%
FY18Y/Y Change
Total Assets
6.1B
↑ 25.81%
Total Liabilities
2.8B
↑ 66.68%
FY19Y/Y Change
Total Assets
6.3B
↑ 2.65%
Total Liabilities
2.6B
↓ 5.67%
FY20Y/Y Change
Total Assets
6.7B
↑ 7.38%
Total Liabilities
2.9B
↑ 10.08%
FY21Y/Y Change
Total Assets
9.6B
↑ 42.58%
Total Liabilities
2.7B
↓ 8.53%
FY22Y/Y Change
Total Assets
11.5B
↑ 19.63%
Total Liabilities
4.3B
↑ 62.06%
FY23Y/Y Change
Total Assets
11.7B
↑ 1.45%
Total Liabilities
4.1B
↓ 4.86%
Q3 FY22Q/Q Change
Total Assets
11.6B
↓ 1.92%
Total Liabilities
4.5B
↓ 6.2%
Q4 FY22Q/Q Change
Total Assets
11.5B
↓ 0.52%
Total Liabilities
4.3B
↓ 3.39%
Q1 FY23Q/Q Change
Total Assets
11.6B
↑ 0.6%
Total Liabilities
4.2B
↓ 2.14%
Q2 FY23Q/Q Change
Total Assets
11.5B
↓ 0.19%
Total Liabilities
4.2B
↓ 1.51%
Q3 FY23Q/Q Change
Total Assets
11.7B
↑ 1.37%
Total Liabilities
4.2B
↑ 0.18%
Q4 FY23Q/Q Change
Total Assets
11.7B
↓ 0.33%
Total Liabilities
4.1B
↓ 1.46%
FY18Y/Y Change
Operating Cash Flow
668.9M
↑ 12.69%
Investing Cash Flow
-1.5B
↑ 297.98%
Financing Cash Flow
844.4M
↓ 470.51%
FY19Y/Y Change
Operating Cash Flow
713.2M
↑ 6.62%
Investing Cash Flow
-351.3M
↓ 76.85%
Financing Cash Flow
-351.4M
↓ 141.62%
FY20Y/Y Change
Operating Cash Flow
486.6M
↓ 31.77%
Investing Cash Flow
-364.5M
↑ 3.76%
Financing Cash Flow
-95.5M
↓ 72.82%
FY21Y/Y Change
Operating Cash Flow
738.6M
↑ 51.79%
Investing Cash Flow
-450.3M
↑ 23.54%
Financing Cash Flow
-311.4M
↑ 226.07%
FY22Y/Y Change
Operating Cash Flow
692.4M
↓ 6.26%
Investing Cash Flow
-1.8B
↑ 306.66%
Financing Cash Flow
1.2B
↓ 483.33%
FY23Y/Y Change
Operating Cash Flow
607.5M
↓ 12.26%
Investing Cash Flow
-449.0M
↓ 75.48%
Financing Cash Flow
-173.9M
↓ 114.57%
Q3 FY22Q/Q Change
Operating Cash Flow
263.9M
↑ 100.23%
Investing Cash Flow
-46.5M
↑ 196.18%
Financing Cash Flow
-368.7M
↓ 12813.79%
Q4 FY22Q/Q Change
Operating Cash Flow
130.7M
↓ 50.47%
Investing Cash Flow
-99.7M
↑ 114.41%
Financing Cash Flow
-134.1M
↓ 63.63%
Q1 FY23Q/Q Change
Operating Cash Flow
166.6M
↑ 27.47%
Investing Cash Flow
-113.3M
↑ 13.64%
Financing Cash Flow
-77.6M
↓ 42.13%
Q2 FY23Q/Q Change
Operating Cash Flow
124.2M
↓ 25.45%
Investing Cash Flow
-82.0M
↓ 27.63%
Financing Cash Flow
-46.8M
↓ 39.69%
Q3 FY23Q/Q Change
Operating Cash Flow
142.5M
↑ 14.73%
Investing Cash Flow
-288.2M
↑ 251.46%
Financing Cash Flow
-43.0M
↓ 8.12%
Q4 FY23Q/Q Change
Operating Cash Flow
174.2M
↑ 22.25%
Investing Cash Flow
-160.8M
↓ 44.21%
Financing Cash Flow
-6.5M
↓ 84.88%

Technicals Summary

Sell

Neutral

Buy

Cooper Companies Inc., The is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Institutional Holdings

  • Vanguard Group Inc

    45.69%
  • BlackRock Inc

    34.97%
  • Veritas Asset Management LLP

    18.16%
  • State Street Corporation

    16.45%
  • T. Rowe Price Investment Management,Inc.

    14.59%
  • Kayne Anderson Rudnick Investment Management LLC

    13.10%

Corporate Announcements

  • Cooper Companies Inc., The Dividends March,2023

    In the quarter ending March,2023. Cooper Companies Inc., The has declared dividend of $0.03

    Read More

Company Information

company overview the cooper companies, inc. ("cooper"​) is a global medical device company publicly traded on the nyse euronext (nyse:coo). cooper is dedicated to being a quality of life company™ with a focus on delivering shareholder value. cooper operates through two business units, coopervision and coopersurgical. coopervision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. coopersurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. headquartered in pleasanton, ca, cooper has approximately 9,000 employees with products sold in over 100 countries. for more information, please visit www.coopercos.com.

Organization
Cooper Companies Inc., The
Employees
15000
CEO
Mr. Albert G. White III
Industry
Health Technology

FAQs